Cargando…
Treatment of Stage 2 Medication-Induced Osteonecrosis of the Jaw: A Case Series
Medication-induced jaw osteonecrosis (MRONJ) is a rare and serious disease with a negative impact on patients’ quality of life, whose exact cause remains unclear and which may have a multifactorial origin. Although there are different therapeutic protocols, there is still no consensus. This case ser...
Autores principales: | Pardo-Zamora, Guillermo, Martínez, Yanet, Moreno, Jose Antonio, Ortiz-Ruíz, Antonio J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908594/ https://www.ncbi.nlm.nih.gov/pubmed/33498884 http://dx.doi.org/10.3390/ijerph18031018 |
Ejemplares similares
-
Non-Incised Papilla Surgical Approach and Leukocyte Platelet-Rich Fibrin in Periodontal Reconstruction of Deep Intrabony Defects: A Case Series
por: Pardo-Zamora, Guillermo, et al.
Publicado: (2021) -
Epi-Mucosa Fixation and Autologous Platelet-Rich Fibrin Treatment in Medication-Related Osteonecrosis of the Jaw
por: Cortese, Antonio, et al.
Publicado: (2021) -
Adalimumab: Another Medication Related to Osteonecrosis of the Jaws?
por: Cassoni, Andrea, et al.
Publicado: (2016) -
Combined approach to treatment of advanced stages of medication-related osteonecrosis of the jaw patients
por: Şahin, Onur, et al.
Publicado: (2021) -
Mesenchymal stem cells in the treatment of osteonecrosis of the jaw
por: Nifosì, Gianfilippo, et al.
Publicado: (2021)